Skip to contentS
Selectis Health, Inc.
S
GBCSSelectis Health, Inc. Q3 2025 · 10-Q
Revenue$10.84M$10.84M+8.2% vs Q3 2024 Net Income$752.37K$752.37KN/M vs Q3 2024 EPS Diluted$0.24$0.24N/M vs Q3 2024 Operating Income-$296,960N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Selectis Health, Inc. · CIK 727346 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$275,795N/M Margins · derivedOperating margin-2.7%+9.0 pt vs Q3 2024
Net margin6.9%+23.0 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 14, 2025 · 45 d after period end